MRI can predict the presence of lymph node involvement in women with early invasive cervical cancer, according to a study in Gynecologic Oncology.
MRI can predict the presence of lymph node involvement in women with early invasive cervical cancer, according to a study in Gynecologic Oncology.
The ACRIN/GOG study enrolled 208 patients with biopsy-proven invasive cervical cancer. Each patient was imaged with CT and MRI prospectively by one onsite radiologist and retrospectively by four independent offsite radiologists. All were blinded to surgical, histopathological, and other imaging findings.
The researchers found lymphatic metastases in 34% of women; 13% had common iliac nodal metastases, and 9% had paraortic nodal metastases. Accurate prediction of histologic lymph node involvement based on tumor size was higher for MRI than for CT, they found.
The study was conducted by Dr. Donald G. Mitchell and colleagues at Thomas Jefferson University Hospital in Philadelphia (2009;112[1]: 95-103).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.